DC
Decheng Capital Portfolio holdings
AUM
$396M
This Quarter Return
+76.72%
1 Year Return
-5.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$746M
AUM Growth
+$746M
(+108%)
Cap. Flow
+$221M
Cap. Flow
% of AUM
29.7%
Top 10 Holdings %
Top 10 Hldgs %
93.39%
Holding
31
New
7
Increased
2
Reduced
2
Closed
9
Top Buys
| 1 |
CG Oncology
CGON
|
$240M |
| 2 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$48.9M |
| 3 |
4D Molecular Therapeutics
FDMT
|
$11.1M |
| 4 |
MoonLake Immunotherapeutics
MLTX
|
$8.37M |
| 5 |
Crinetics Pharmaceuticals
CRNX
|
$7.39M |
Top Sells
| 1 |
Pacific Biosciences
PACB
|
$28.8M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$19.6M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$14.9M |
| 4 |
Roivant Sciences
ROIV
|
$14.4M |
| 5 |
argenx
ARGX
|
$10.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Roivant Sciences
ROIV
$8.15B
| – | – | -1,279,700 | Closed | -$14.4M |
|
27
SCYNEXIS
SCYX
$34.9M
| – | – | -555,555 | Closed | -$1.24M |
|
|
SLRN
28
DELISTED
ACELYRIN
SLRN
| – | – | -1,370,951 | Closed | -$10.2M |
|
29
Terns Pharmaceuticals
TERN
$609M
| – | – | -714,285 | Closed | -$4.64M |
|
|
KRTX
30
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – | -47,000 | Closed | -$14.9M |
|
|
IMGN
31
DELISTED
Immunogen Inc
IMGN
| – | – | -659,928 | Closed | -$19.6M |
|